In a recent study, researchers at the Norman Fixel Institute for Neurological Diseases at UF Health and the University of Florida College of Pharmacy used Medicare data to compare the rate of hospitalizations and deaths between two common Parkinson’s disease medications: pimavanserin and quetiapine.
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
A recent Parkinson’s Foundation study estimates that nearly 90,000 people in the U.S. are diagnosed with Parkinson’s disease each year.
According to a pilot study at the Norman Fixel Institute for Neurological Diseases, group physical and occupational therapy sessions may be beneficial for symptom improvement and motivation levels in people living with Parkinson’s.
Study co-authored by Dr. Karen Hegland found sensorimotor training for airway protection improved cough-related outcomes in Parkinson’s patients.
For his work’s impact on the lives of people living with Parkinson’s, Dr. Okun receives the 2022 Tom Isaacs Scientific Award from Cure Parkinson’s and Van Andel Institute.
Drs. Ramzi Salloum and Michael Okun co-authored new JAMA Neurology viewpoint article.
Researchers find impulse control disorders are likely more common with Parkinson’s disease due to underreporting by patients in questionnaires.
Researchers find that the brain may benefit from a novel stimulation pattern called TOPS instead of chronic continuous, standard stimulation with DBS.
The PD Movers organization has put together a colorful and personalized story book called “The PD Movers, We Keep Moving: Living and Thriving with Parkinson’s disease in our Black and African American Communities.” This books is aimed at shedding the light on the challenges and opportunities someone…
